| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |